Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
25.90
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Jan 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Hims & Hers Stock Is Poised for a Major Surge in 2025
January 10, 2025
The focus is on GLP-1s, but there's more to Hims & Hers than one product.
Via
The Motley Fool
Evaluating NYSE:HIMS for Growth Investment Opportunities.
January 10, 2025
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
Via
Chartmill
What's Going On With Hims & Hers Health Stock?
January 09, 2025
Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst expectations.
Via
Benzinga
What 12 Analyst Ratings Have To Say About Hims & Hers Health
January 06, 2025
Via
Benzinga
Stock Picks 2024 Year In Review
January 01, 2025
Unlike 2023, 2024 was a very concentrated year, with just a few key large-cap stocks driving much of the index's returns.
Via
Talk Markets
Topics
Stocks / Equities
Is Hims & Hers Health a Millionaire Maker?
January 01, 2025
Arguments are piling up for why the company might fail, but the business continues to deliver strong results.
Via
The Motley Fool
Is NYSE:HIMS suited for growth investing?
December 19, 2024
HIMS & HERS HEALTH INC (NYSE:HIMS) may be suited for growth investing, we'll explore why in this article.
Via
Chartmill
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
December 17, 2024
Via
Benzinga
Hims & Hers Health Unusual Options Activity
December 11, 2024
Via
Benzinga
3 Hot Stocks That Can Double Again in 2025
December 31, 2024
Three unlikely winners of 2024 can lead the way in the year ahead.
Via
The Motley Fool
Prediction: This Will Be Amazon's Next Big Acquisition
December 27, 2024
Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 26, 2024
Via
Benzinga
Will The Falling Hims & Hers Stock Price Recover In 2025?
December 22, 2024
Hims & Hers share price has crashed by over 20% this year after an unfavorable FDA ruling.
Via
Talk Markets
Topics
Stocks / Equities
Exposures
Product Safety
Hims & Hers Stock: Growth, Noise, and Where to Focus Now
December 20, 2024
Hims & Hers stock is full of noise, but what's the signal for investors?
Via
The Motley Fool
Where Hims & Hers Health Stands With Analysts
December 02, 2024
Via
Benzinga
Hims & Hers Health Are Falling Today: What's Going On?
December 19, 2024
Hims & Hers Health, Inc. (NYSE: HIMS) are trading lower Thursday. The U.S. Food and Drug Administration (FDA) issued a new decision regarding the status of tirzepatide injection shortages, which have...
Via
Benzinga
From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty
December 19, 2024
Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility.
Via
Talk Markets
Topics
Stocks / Equities
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
December 19, 2024
Compounders now have until late March to wind down their operations, depending on their licensing.
Via
Investor's Business Daily
Exposures
Product Safety
This Is Huge News for Eli Lilly Investors
December 19, 2024
Eli Lilly just gave investors several reasons to cheer.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 18, 2024
Via
Benzinga
Be Careful In This Unforgiving Market. The Tide Is Turning.
December 15, 2024
Via
Talk Markets
Topics
Stocks / Equities
Josh Brown Unveils The 'Degen Dow,' A Basket Of 30 Retail Darlings Spanning All 'Major Degen Food Groups'
December 12, 2024
Ritholtz Wealth Management’s Josh Brown created a new index that tracks the most popular stocks in some of the hottest themes of the market.
Via
Benzinga
4 Stocks That Crushed Analyst Estimates by More Than Double
December 11, 2024
Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.
Via
MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
December 10, 2024
Via
Benzinga
Amazon’s Healthcare Gamble: A New Era of Medical Disruption
December 10, 2024
Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
December 05, 2024
Via
Benzinga
2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
December 05, 2024
Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.
Via
MarketBeat
Topics
Government
Lawsuit
Exposures
Financial
Legal
Political
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
December 05, 2024
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
December 04, 2024
Via
Benzinga
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
December 01, 2024
8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.